Imagion Biosystems Limited Stock Fundamentals
| IBXXF Stock | USD 0.04 0.00 0.00% |
Imagion Biosystems Limited fundamentals help investors to digest information that contributes to Imagion Biosystems' financial success or failures. It also enables traders to predict the movement of Imagion Pink Sheet. The fundamental analysis module provides a way to measure Imagion Biosystems' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imagion Biosystems pink sheet.
Imagion |
Imagion Biosystems Limited Company Operating Margin Analysis
Imagion Biosystems' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Imagion Biosystems Operating Margin | (30.08) % |
Most of Imagion Biosystems' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Imagion Biosystems Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Imagion Biosystems Limited has an Operating Margin of -30.0828%. This is 14.25% lower than that of the Healthcare sector and 52.52% lower than that of the Diagnostics & Research industry. The operating margin for all United States stocks is notably higher than that of the company.
Imagion Biosystems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Imagion Biosystems's current stock value. Our valuation model uses many indicators to compare Imagion Biosystems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Imagion Biosystems competition to find correlations between indicators driving Imagion Biosystems's intrinsic value. More Info.Imagion Biosystems Limited is rated third overall in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Imagion Biosystems' earnings, one of the primary drivers of an investment's value.Imagion Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Imagion Biosystems' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Imagion Biosystems could also be used in its relative valuation, which is a method of valuing Imagion Biosystems by comparing valuation metrics of similar companies.Imagion Biosystems is currently under evaluation in operating margin category among its peers.
Imagion Fundamentals
| Return On Equity | -0.94 | |||
| Return On Asset | -0.44 | |||
| Operating Margin | (30.08) % | |||
| Current Valuation | 21.85 M | |||
| Shares Outstanding | 1.12 B | |||
| Shares Owned By Insiders | 9.27 % | |||
| Price To Book | 3.16 X | |||
| Price To Sales | 60.01 X | |||
| Revenue | 232.87 K | |||
| Gross Profit | 151.53 K | |||
| EBITDA | (5.62 M) | |||
| Net Income | (6.02 M) | |||
| Cash And Equivalents | 8.52 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 5.12 M | |||
| Debt To Equity | 0.62 % | |||
| Current Ratio | 4.24 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (5.07 M) | |||
| Earnings Per Share | (0) X | |||
| Beta | 2.62 | |||
| Market Capitalization | 28.03 M | |||
| Total Asset | 14.12 M | |||
| Z Score | 3.0 | |||
| Net Asset | 14.12 M |
About Imagion Biosystems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Imagion Biosystems Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imagion Biosystems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imagion Biosystems Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. The company was incorporated in 2016 and is based in San Diego, California. Imagion Biosystems operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Imagion Pink Sheet
Imagion Biosystems financial ratios help investors to determine whether Imagion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Imagion with respect to the benefits of owning Imagion Biosystems security.